RecruitingNot ApplicableNCT06824688
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
Efficacy and Safety Assessment of Single-port Versus Multi-port Robotic Surgery for Rectal Cancer: a Phase 2a Non-randomized Controlled Study Based on the IDEAL Framework
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Enrollment
40 participants
Start Date
Oct 23, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Single-port versus multi-port robotic surgery for rectal cancer
Eligibility
Min Age: 18 Years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURESingle-port robotic total mesorectal excision
Single-port robotic total mesorectal excision
PROCEDUREMulti-port robotic total mesorectal excision
Multi-port robotic total mesorectal excision
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06824688
Related Trials
Evaluation of Gynecological and Sexual Sequelae
NCT073898631 location
Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial
NCT068500901 location
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
NCT069116841 location
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
NCT066476801 location
Site of Tracheal Extubation and Operating Room Efficiency During Robot-assisted Surgery
NCT073328061 location